Raymond James Reinstates Outperform on CareTrust REIT, Announces $43 Price Target

Benzinga Newsdesk www.benzinga.com Positive 78.2%

Neg 0% Neu 0% Pos 78.2%

Raymond James analyst David Rodgers reinstates CareTrust REIT (NYSE:CTRE) with a Outperform and announces $43 price target.